n-carbomethoxycarbonyl-prolyl-phenylalanyl-benzyl ester has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burakoff, SJ; McKeating, JA; Moore, JP; Schreiber, SL; Simpson, G; Weiss, RA | 1 |
1 other study(ies) available for n-carbomethoxycarbonyl-prolyl-phenylalanyl-benzyl ester and HIV Coinfection
| Article | Year |
|---|---|
CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.
Topics: Animals; Antiviral Agents; Benzyl Compounds; CD4 Antigens; Cell Survival; Cells, Cultured; Dipeptides; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; In Vitro Techniques; Lentivirus; Protein Binding; Retroviridae; Virion | 1992 |